Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 127,604 shares at $75.10 ($9.6M) on 2024-05-29, disclosed to the SEC on 2024-05-30.
Scheduled sale ($9.6M) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.10 | 63,802 | $4.8M | 50.0% |
| 2 | $75.10 | 63,802 | $4.8M | 50.0% |
| Total | $75.10 avg | 127,604 | $9.6M | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-03-19 | $1.9M | — | Filing → |